Date: 2015-04-07
Type of information: R&D agreement
Compound: novel antibiotics
Company: Vernalis (UK) Taisho Pharmaceutical (Japan)
Therapeutic area: Infectious diseases
Type agreement: R&D
Action mechanism:
Disease:
Details: * On April 7, 2015, Vernalis announced that it has entered into a drug discovery collaboration with Taisho Pharmaceutical Co., Ltd., utilizing Vernalis’ fragment and structure-based drug discovery platform against an undisclosed target for the development of potential antibiotic agents.
Financial terms: The financial terms of this collaboration are not disclosed.
Latest news:
